5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)

Bibliographic Details
Main Authors: M. Callaghan, K.I. Ataga, L. De Franceschi, C. Minniti, N. Balachandran, D.-.C. Imbs, T. Perretti, J. Ramos, A. Sostelly, P. Bartolucci
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000928320.14894.77
_version_ 1797283716497670144
author M. Callaghan
K.I. Ataga
L. De Franceschi
C. Minniti
N. Balachandran
D.-.C. Imbs
T. Perretti
J. Ramos
A. Sostelly
P. Bartolucci
author_facet M. Callaghan
K.I. Ataga
L. De Franceschi
C. Minniti
N. Balachandran
D.-.C. Imbs
T. Perretti
J. Ramos
A. Sostelly
P. Bartolucci
author_sort M. Callaghan
collection DOAJ
first_indexed 2024-03-07T17:34:51Z
format Article
id doaj.art-361c984f428147c282c308015cd09ff4
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T17:34:51Z
publishDate 2023-04-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-361c984f428147c282c308015cd09ff42024-03-02T16:54:12ZengWileyHemaSphere2572-92412023-04-017S1262610.1097/01.HS9.0000928320.14894.77202304001-000485612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)M. CallaghanK.I. AtagaL. De FranceschiC. MinnitiN. BalachandranD.-.C. ImbsT. PerrettiJ. RamosA. SostellyP. Bartoluccihttp://journals.lww.com/10.1097/01.HS9.0000928320.14894.77
spellingShingle M. Callaghan
K.I. Ataga
L. De Franceschi
C. Minniti
N. Balachandran
D.-.C. Imbs
T. Perretti
J. Ramos
A. Sostelly
P. Bartolucci
5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
HemaSphere
title 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_full 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_fullStr 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_full_unstemmed 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_short 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_sort 5612539 trial in progress the randomized double blind placebo controlled phase 2a crosswalk c trial evaluating the efficacy of crovalimab as adjunct treatment in the prevention of vaso occlusive episodes voes in patients pts with sickle cell disease scd
url http://journals.lww.com/10.1097/01.HS9.0000928320.14894.77
work_keys_str_mv AT mcallaghan 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT kiataga 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT ldefranceschi 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT cminniti 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT nbalachandran 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT dcimbs 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT tperretti 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT jramos 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT asostelly 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT pbartolucci 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd